Similar articles

• [Pyoderma gangrenosum in Crohn's disease].

  Baryshnikov EN, Neĭman KP. Baryshnikov EN, et al. Eksp Klin Gastroenterol. 2008;(5):92-4. Eksp Klin Gastroenterol. 2008. PMID: 19145923 Russian. No abstract available.
• Use of infliximab in pyoderma gangrenosum.

  Hewitt D, Tait C. Hewitt D, et al. Australas J Dermatol. 2007 May;48(2):95-8. doi: 10.1111/j.1440-0960.2007.00344.x. Australas J Dermatol. 2007. PMID: 17535196
• Anti-tumor necrosis factor alpha monoclonal antibody (infliximab) for the treatment of Pyoderma gangrenosum associated with Crohn's disease.

  Zaccagna A, Bertone A, Puiatti P, Picciotto F, Sprujevnik T, Santucci R, Rossini FP. Zaccagna A, et al. Eur J Dermatol. 2003 May-Jun;13(3):258-60. Eur J Dermatol. 2003. PMID: 12804985
• Pyoderma gangrenosum: an updated review.

  Ruocco E, Sangiuliano S, Gravina AG, Miranda A, Nicoletti G. Ruocco E, et al. J Eur Acad Dermatol Venereol. 2009 Sep;23(9):1008-17. doi: 10.1111/j.1468-3083.2009.03199.x. Epub 2009 Mar 11. J Eur Acad Dermatol Venereol. 2009. PMID: 19470075 Review.
• Gastrointestinal: A rare case of concurrent vulvar Crohn's disease and pyoderma gangrenosum.

  Bommireddipally J, Broussard K, Osman H, Uhlhorn A, Loganantharaj N. Bommireddipally J, et al. J Gastroenterol Hepatol. 2024 Mar;39(3):417-419. doi: 10.1111/jgh.16393. Epub 2023 Nov 29. J Gastroenterol Hepatol. 2024. PMID: 38030955 Review. No abstract available.